Todd Franklin Watanabe, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), sold 29,806 shares at $11.12 ($331K) on 2024-03-04, disclosed to the SEC on 2024-03-06.
Scheduled sale ($331k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.12 | 14,903 | $166K | 50.0% |
| 2 | $11.12 | 14,903 | $166K | 50.0% |
| Total | $11.12 avg | 29,806 | $331K | 100% |
| Filing → |
| ARQT | SELL | 2025-03-20 | $21K | — | Filing → |
| ARQT | SELL | 2025-03-04 | $654K | — | Filing → |
| ARQT | SELL | 2025-02-04 | $490K | — | Filing → |